A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
2012
The identification of 9 susceptibility genes for
paraganglioma/
pheochromocytomabetween 2001and 2010 has led to the development of routine
genetic tests. To study the evolution in
genetic screeningfor
paraganglioma/
pheochromocytomaover the past decade, we carried out a retrospective study on the tests performed in our laboratory from January 2001 to December 2010. A
genetic testfor
paraganglioma/
pheochromocytomawas assessed for 2 499 subjects, 1 620
index cases, and 879 presymptomatic familial
genetic tests. A
germline mutationin a PGL/PCC susceptibility gene was identified in 363
index cases(22.4%): 269 in SDHx genes (137 in
SDHB, 100 in
SDHD, 30 in SDHC , 2 in
SDHA), 64 in VHL , 23 in RET , and 7 in TMEM127 . A presymptomatic
paraganglioma/
pheochromocytomatest was positive in 427 subjects. Advances in molecular screening techniques led to an increase in the total number of mutation-carriers diagnosed each year. Overall, during the last decade, our laboratory identified a
germline mutationin 44.7% of patients with a suspect hereditary PGL/PCC and in 8% of patients with an apparently sporadic PGL/PCC. During the past decade, the discoveries of new
paraganglioma/
pheochromocytomasusceptibility genes and the subsequent progress of molecular screening techniques have enabled us to diagnose a hereditary
paraganglioma/
pheochromocytomain about 22% of patients tested in routine practice. This
genetic testingis of major importance for the follow-up of affected patients and for the
genetic counsellingof their families.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
0
References
86
Citations
NaN
KQI